Equities Research Analysts’ price target changes for Friday, February 27th:
Applied Optoelectronics (NASDAQ:AAOI) had its target price boosted by Needham & Company LLC from $43.00 to $80.00. Needham & Company LLC currently has a buy rating on the stock.
Autodesk (NASDAQ:ADSK) had its price target increased by JPMorgan Chase & Co. from $319.00 to $336.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Autodesk (NASDAQ:ADSK) had its target price increased by Barclays PLC from $300.00 to $315.00. They currently have an overweight rating on the stock.
Autodesk (NASDAQ:ADSK) had its price target lowered by BTIG Research from $365.00 to $300.00. The firm currently has a buy rating on the stock.
Autodesk (NASDAQ:ADSK) had its target price cut by Wells Fargo & Company from $365.00 to $350.00. Wells Fargo & Company currently has an overweight rating on the stock.
Autodesk (NASDAQ:ADSK) had its price target cut by Royal Bank Of Canada from $340.00 to $335.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Autodesk (NASDAQ:ADSK) had its price target trimmed by DA Davidson from $375.00 to $325.00. DA Davidson currently has a buy rating on the stock.
Agilon Health (NYSE:AGL) had its target price trimmed by Barclays PLC from $1.00 to $0.50. The firm currently has an underweight rating on the stock.
Agilon Health (NYSE:AGL) had its price target raised by Wells Fargo & Company from $1.00 to $1.50. The firm currently has an overweight rating on the stock.
Ardagh Metal Packaging (NYSE:AMBP) had its target price boosted by Wells Fargo & Company from $4.00 to $5.00. They currently have an equal weight rating on the stock.
Amphastar Pharmaceuticals (NASDAQ:AMPH) had its price target cut by Needham & Company LLC from $34.00 to $30.00. The firm currently has a buy rating on the stock.
Amphastar Pharmaceuticals (NASDAQ:AMPH) had its price target trimmed by Wells Fargo & Company from $34.00 to $30.00. Wells Fargo & Company currently has an overweight rating on the stock.
AMERISAFE (NASDAQ:AMSF) had its target price cut by Truist Financial Corporation from $45.00 to $36.00. The firm currently has a hold rating on the stock.
American Woodmark (NASDAQ:AMWD) had its target price cut by Robert W. Baird from $60.00 to $55.00. The firm currently has a neutral rating on the stock.
Amazon.com (NASDAQ:AMZN) had its price target cut by Evercore Inc from $335.00 to $285.00. Evercore Inc currently has an outperform rating on the stock.
APA (NASDAQ:APA) had its target price raised by JPMorgan Chase & Co. from $25.00 to $29.00. They currently have a neutral rating on the stock.
Arbe Robotics (NASDAQ:ARBE) had its price target cut by Canaccord Genuity Group Inc. from $1.75 to $1.25. They currently have a buy rating on the stock.
argenex (NASDAQ:ARGX) had its target price cut by Royal Bank Of Canada from $925.00 to $890.00. Royal Bank Of Canada currently has an outperform rating on the stock.
argenex (NASDAQ:ARGX) had its price target lowered by Wells Fargo & Company from $1,317.00 to $1,247.00. The firm currently has an overweight rating on the stock.
argenex (NASDAQ:ARGX) had its price target raised by Citizens Jmp from $925.00 to $944.00. They currently have a market outperform rating on the stock.
argenex (NASDAQ:ARGX) had its price target increased by Robert W. Baird from $858.00 to $867.00. They currently have a neutral rating on the stock.
argenex (NASDAQ:ARGX) had its price target raised by HC Wainwright from $915.00 to $940.00. The firm currently has a buy rating on the stock.
argenex (NASDAQ:ARGX) had its target price lowered by Guggenheim from $1,160.00 to $1,120.00. Guggenheim currently has a buy rating on the stock.
Archrock (NYSE:AROC) had its price target raised by Wells Fargo & Company from $30.00 to $39.00. The firm currently has an overweight rating on the stock.
Arcutis Biotherapeutics (NASDAQ:ARQT) had its target price raised by Guggenheim from $34.00 to $35.00. They currently have a buy rating on the stock.
AvePoint (NASDAQ:AVPT) had its price target lowered by Cantor Fitzgerald from $18.00 to $15.00. They currently have an overweight rating on the stock.
AutoZone (NYSE:AZO) had its price target increased by Evercore Inc from $4,100.00 to $4,125.00. They currently have an outperform rating on the stock.
Bath & Body Works (NYSE:BBWI) had its price target raised by Telsey Advisory Group from $17.00 to $23.00. Telsey Advisory Group currently has a market perform rating on the stock.
Baidu (NASDAQ:BIDU) had its price target trimmed by Morgan Stanley from $150.00 to $135.00. They currently have an equal weight rating on the stock.
BJ’s Wholesale Club (NYSE:BJ) had its price target increased by Wells Fargo & Company from $105.00 to $110.00. The firm currently has an overweight rating on the stock.
TopBuild (NYSE:BLD) had its target price raised by Royal Bank Of Canada from $410.00 to $433.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
TopBuild (NYSE:BLD) had its target price trimmed by Benchmark Co. from $515.00 to $500.00. Benchmark Co. currently has a buy rating on the stock.
TopBuild (NYSE:BLD) had its target price cut by Wells Fargo & Company from $600.00 to $525.00. They currently have an overweight rating on the stock.
Bentley Systems (NASDAQ:BSY) had its target price cut by Mizuho from $62.00 to $50.00. They currently have an outperform rating on the stock.
Bentley Systems (NASDAQ:BSY) had its price target trimmed by Oppenheimer Holdings, Inc. from $53.00 to $43.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Baldwin Insurance Group (NASDAQ:BWIN) had its price target cut by Wells Fargo & Company from $27.00 to $21.00. Wells Fargo & Company currently has an equal weight rating on the stock.
BlueLinx (NYSE:BXC) had its price target reduced by Benchmark Co. from $83.00 to $75.00. Benchmark Co. currently has a buy rating on the stock.
Cable One (NYSE:CABO) had its target price reduced by Wells Fargo & Company from $107.00 to $90.00. They currently have an underweight rating on the stock.
Caris Life Sciences (NASDAQ:CAI) had its target price trimmed by BTIG Research from $45.00 to $38.00. The firm currently has a buy rating on the stock.
Caris Life Sciences (NASDAQ:CAI) had its target price boosted by Robert W. Baird from $26.00 to $28.00. Robert W. Baird currently has an outperform rating on the stock.
Carrier Global (NYSE:CARR) had its target price increased by Wolfe Research from $71.00 to $74.00. Wolfe Research currently has an outperform rating on the stock.
Crescent Capital BDC (NASDAQ:CCAP) had its target price reduced by Wells Fargo & Company from $14.00 to $13.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Clear Channel Outdoor (NYSE:CCO) had its target price raised by Wells Fargo & Company from $2.00 to $2.43. The firm currently has an equal weight rating on the stock.
Celsius (NASDAQ:CELH) had its price target increased by Needham & Company LLC from $70.00 to $75.00. The firm currently has a buy rating on the stock.
Certara (NASDAQ:CERT) had its target price lowered by Barclays PLC from $13.00 to $8.00. Barclays PLC currently has an overweight rating on the stock.
Carlyle Secured Lending (NASDAQ:CGBD) had its price target trimmed by Wells Fargo & Company from $14.00 to $13.00. Wells Fargo & Company currently has an overweight rating on the stock.
Churchill Downs (NASDAQ:CHDN) had its target price lowered by Wells Fargo & Company from $125.00 to $124.00. The firm currently has an overweight rating on the stock.
Chemed (NYSE:CHE) had its price target lowered by Oppenheimer Holdings, Inc. from $580.00 to $500.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Coupang (NYSE:CPNG) had its price target trimmed by Mizuho from $32.00 to $25.00. They currently have a neutral rating on the stock.
Cheniere Energy Partners (NYSE:CQP) had its target price boosted by Barclays PLC from $55.00 to $60.00. They currently have an underweight rating on the stock.
CrowdStrike (NASDAQ:CRWD) had its price target reduced by Jefferies Financial Group Inc. from $600.00 to $500.00. They currently have a buy rating on the stock.
CoreWeave (NASDAQ:CRWV) had its target price raised by Truist Financial Corporation from $84.00 to $85.00. They currently have a hold rating on the stock.
CoreWeave (NASDAQ:CRWV) had its price target lowered by Mizuho from $100.00 to $95.00. Mizuho currently has a neutral rating on the stock.
CoreWeave (NASDAQ:CRWV) had its target price increased by DA Davidson from $110.00 to $125.00. They currently have a buy rating on the stock.
Carlisle Companies (NYSE:CSL) had its target price raised by Oppenheimer Holdings, Inc. from $400.00 to $435.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Castle Biosciences (NASDAQ:CSTL) had its price target boosted by Robert W. Baird from $41.00 to $44.00. The firm currently has an outperform rating on the stock.
Centuri (NYSE:CTRI) had its target price increased by Cantor Fitzgerald from $34.00 to $35.25. Cantor Fitzgerald currently has an overweight rating on the stock.
Donaldson (NYSE:DCI) had its price target lowered by Robert W. Baird from $110.00 to $104.00. Robert W. Baird currently has an outperform rating on the stock.
Ducommun (NYSE:DCO) had its price target raised by Truist Financial Corporation from $124.00 to $136.00. Truist Financial Corporation currently has a buy rating on the stock.
Dell Technologies (NYSE:DELL) had its target price lowered by Piper Sandler from $172.00 to $167.00. The firm currently has an overweight rating on the stock.
Dell Technologies (NYSE:DELL) had its target price increased by Morgan Stanley from $101.00 to $110.00. Morgan Stanley currently has an underweight rating on the stock.
Dell Technologies (NYSE:DELL) had its target price boosted by Raymond James Financial, Inc. from $166.00 to $182.00. The firm currently has an outperform rating on the stock.
Dell Technologies (NYSE:DELL) had its price target raised by Mizuho from $175.00 to $180.00. They currently have an outperform rating on the stock.
Dell Technologies (NYSE:DELL) had its target price boosted by Barclays PLC from $148.00 to $168.00. Barclays PLC currently has an overweight rating on the stock.
Definitive Healthcare (NASDAQ:DH) had its price target reduced by Stephens from $3.00 to $2.00. They currently have an equal weight rating on the stock.
Dorman Products (NASDAQ:DORM) had its target price lowered by Wells Fargo & Company from $150.00 to $140.00. Wells Fargo & Company currently has an overweight rating on the stock.
Duolingo (NASDAQ:DUOL) had its target price lowered by Needham & Company LLC from $300.00 to $145.00. The firm currently has a buy rating on the stock.
DoubleVerify (NYSE:DV) had its price target reduced by Royal Bank Of Canada from $17.00 to $14.00. The firm currently has an outperform rating on the stock.
Ecovyst (NYSE:ECVT) had its target price increased by KeyCorp from $11.00 to $14.00. KeyCorp currently has an overweight rating on the stock.
Excelerate Energy (NYSE:EE) had its target price boosted by Wells Fargo & Company from $29.00 to $39.00. The firm currently has an equal weight rating on the stock.
EMCOR Group (NYSE:EME) had its price target boosted by Robert W. Baird from $713.00 to $808.00. The firm currently has an outperform rating on the stock.
Emerson Electric (NYSE:EMR) had its price target reduced by Wolfe Research from $177.00 to $176.00. Wolfe Research currently has an outperform rating on the stock.
Eos Energy Enterprises (NASDAQ:EOSE) had its target price lowered by Roth Mkm from $12.00 to $6.00. They currently have a neutral rating on the stock.
Elastic (NYSE:ESTC) had its price target lowered by Barclays PLC from $78.00 to $76.00. They currently have an overweight rating on the stock.
Elastic (NYSE:ESTC) had its target price cut by Piper Sandler from $110.00 to $85.00. The firm currently has an overweight rating on the stock.
Elastic (NYSE:ESTC) had its target price trimmed by Wells Fargo & Company from $75.00 to $60.00. They currently have an equal weight rating on the stock.
Elastic (NYSE:ESTC) had its price target trimmed by Oppenheimer Holdings, Inc. from $100.00 to $85.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Elastic (NYSE:ESTC) had its target price cut by Truist Financial Corporation from $105.00 to $80.00. The firm currently has a buy rating on the stock.
First Advantage (NYSE:FA) had its price target trimmed by Barclays PLC from $18.00 to $14.00. They currently have an equal weight rating on the stock.
Fastenal (NASDAQ:FAST) had its price target raised by Wolfe Research from $42.00 to $43.00. Wolfe Research currently has an underperform rating on the stock.
Figure Technology Solutions (NASDAQ:FIGR) had its price target reduced by Needham & Company LLC from $71.00 to $55.00. The firm currently has a buy rating on the stock.
Figure Technology Solutions (NASDAQ:FIGR) had its price target cut by Keefe, Bruyette & Woods from $62.00 to $55.00. They currently have an outperform rating on the stock.
FIGS (NYSE:FIGS) had its price target boosted by Telsey Advisory Group from $9.00 to $15.00. Telsey Advisory Group currently has a market perform rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its target price lowered by Needham & Company LLC from $300.00 to $150.00. The firm currently has a buy rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its target price lowered by BTIG Research from $230.00 to $180.00. The firm currently has a buy rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its price target cut by Barclays PLC from $304.00 to $225.00. The firm currently has an overweight rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its price target reduced by Citizens Jmp from $275.00 to $195.00. Citizens Jmp currently has a market outperform rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its target price cut by Truist Financial Corporation from $260.00 to $160.00. They currently have a buy rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its target price reduced by Benchmark Co. from $285.00 to $175.00. Benchmark Co. currently has a buy rating on the stock.
Shift4 Payments (NYSE:FOUR) had its price target trimmed by Keefe, Bruyette & Woods from $72.00 to $60.00. They currently have a market perform rating on the stock.
Shift4 Payments (NYSE:FOUR) had its target price cut by Wells Fargo & Company from $77.00 to $55.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Frontline (NYSE:FRO) had its target price increased by BTIG Research from $35.00 to $42.00. They currently have a buy rating on the stock.
FS KKR Capital (NYSE:FSK) had its target price trimmed by Royal Bank Of Canada from $17.00 to $15.00. They currently have a sector perform rating on the stock.
FS KKR Capital (NYSE:FSK) had its target price trimmed by Wells Fargo & Company from $15.00 to $11.00. The firm currently has an equal weight rating on the stock.
FTAI Aviation (NASDAQ:FTAI) had its target price boosted by Barclays PLC from $260.00 to $350.00. They currently have an overweight rating on the stock.
Fortrea (NASDAQ:FTRE) had its price target trimmed by Robert W. Baird from $19.00 to $16.00. Robert W. Baird currently has an outperform rating on the stock.
Fortrea (NASDAQ:FTRE) had its target price cut by Barclays PLC from $15.00 to $12.00. They currently have an equal weight rating on the stock.
GoodRx (NASDAQ:GDRX) had its price target trimmed by Mizuho from $4.00 to $3.00. They currently have a neutral rating on the stock.
Structure Therapeutics (NASDAQ:GPCR) had its price target trimmed by Citizens Jmp from $120.00 to $113.00. They currently have a market outperform rating on the stock.
GitLab (NASDAQ:GTLB) had its target price cut by Cantor Fitzgerald from $40.00 to $30.00. The firm currently has a neutral rating on the stock.
Gray Media (NYSE:GTN) had its price target raised by Benchmark Co. from $10.00 to $12.00. Benchmark Co. currently has a buy rating on the stock.
Hilton Grand Vacations (NYSE:HGV) had its price target trimmed by Mizuho from $73.00 to $69.00. The firm currently has an outperform rating on the stock.
Hormel Foods (NYSE:HRL) had its price target raised by Stephens from $25.00 to $27.00. Stephens currently has an equal weight rating on the stock.
Integra LifeSciences (NASDAQ:IART) had its target price reduced by Wells Fargo & Company from $13.00 to $12.00. The firm currently has an equal weight rating on the stock.
Installed Building Products (NYSE:IBP) had its target price boosted by Royal Bank Of Canada from $203.00 to $255.00. The firm currently has an underperform rating on the stock.
Installed Building Products (NYSE:IBP) had its price target reduced by Wells Fargo & Company from $355.00 to $340.00. They currently have an equal weight rating on the stock.
Intuit (NASDAQ:INTU) had its target price lowered by Royal Bank Of Canada from $850.00 to $600.00. The firm currently has an outperform rating on the stock.
Intuit (NASDAQ:INTU) had its price target trimmed by Stifel Nicolaus from $800.00 to $500.00. Stifel Nicolaus currently has a buy rating on the stock.
Intuit (NASDAQ:INTU) had its target price reduced by Citigroup Inc. from $803.00 to $649.00. Citigroup Inc. currently has a buy rating on the stock.
Intuit (NASDAQ:INTU) had its target price reduced by JPMorgan Chase & Co. from $750.00 to $605.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Intuit (NASDAQ:INTU) had its target price reduced by The Goldman Sachs Group, Inc. from $720.00 to $519.00. They currently have a neutral rating on the stock.
Intuit (NASDAQ:INTU) had its target price cut by BMO Capital Markets from $624.00 to $550.00. They currently have an outperform rating on the stock.
Intuit (NASDAQ:INTU) had its price target reduced by Oppenheimer Holdings, Inc. from $696.00 to $558.00. The firm currently has an outperform rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price raised by Piper Sandler from $87.00 to $100.00. The firm currently has an overweight rating on the stock.
Samsara (NYSE:IOT) had its price target reduced by KeyCorp from $55.00 to $40.00. KeyCorp currently has an overweight rating on the stock.
Disc Medicine (NASDAQ:IRON) had its price target cut by Truist Financial Corporation from $114.00 to $83.00. They currently have a buy rating on the stock.
Illinois Tool Works (NYSE:ITW) had its target price boosted by Wolfe Research from $276.00 to $295.00. The firm currently has an underperform rating on the stock.
Janux Therapeutics (NASDAQ:JANX) had its price target cut by Guggenheim from $72.00 to $68.00. They currently have a buy rating on the stock.
Janux Therapeutics (NASDAQ:JANX) had its target price lowered by Cantor Fitzgerald from $150.00 to $100.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Johnson Controls International (NYSE:JCI) had its price target boosted by Wolfe Research from $149.00 to $161.00. The firm currently has an outperform rating on the stock.
OrthoPediatrics (NASDAQ:KIDS) had its target price boosted by BTIG Research from $23.00 to $24.00. They currently have a buy rating on the stock.
OrthoPediatrics (NASDAQ:KIDS) had its target price increased by Needham & Company LLC from $26.00 to $30.00. They currently have a buy rating on the stock.
Kinder Morgan (NYSE:KMI) had its price target increased by Royal Bank Of Canada from $30.00 to $32.00. The firm currently has a sector perform rating on the stock.
Kinetik (NYSE:KNTK) had its target price increased by Wells Fargo & Company from $40.00 to $44.00. The firm currently has an equal weight rating on the stock.
Kimbell Royalty (NYSE:KRP) had its price target trimmed by Mizuho from $17.00 to $16.00. They currently have a neutral rating on the stock.
nLight (NASDAQ:LASR) had its target price increased by Needham & Company LLC from $48.00 to $70.00. They currently have a buy rating on the stock.
nLight (NASDAQ:LASR) had its target price boosted by Cantor Fitzgerald from $40.00 to $62.50. They currently have an overweight rating on the stock.
LandBridge (NYSE:LB) had its price target raised by Barclays PLC from $57.00 to $75.00. The firm currently has an equal weight rating on the stock.
Ligand Pharmaceuticals (NASDAQ:LGND) had its price target boosted by Oppenheimer Holdings, Inc. from $275.00 to $277.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Lindblad Expeditions (NASDAQ:LIND) had its target price raised by Benchmark Co. from $18.00 to $25.00. They currently have a buy rating on the stock.
Lineage (NASDAQ:LINE) had its price target raised by Piper Sandler from $41.00 to $43.00. They currently have a neutral rating on the stock.
LivaNova (NASDAQ:LIVN) had its target price raised by Barclays PLC from $67.00 to $73.00. Barclays PLC currently has an equal weight rating on the stock.
Cheniere Energy (NYSE:LNG) had its price target increased by Barclays PLC from $259.00 to $271.00. Barclays PLC currently has an overweight rating on the stock.
Cheniere Energy (NYSE:LNG) had its price target increased by TD Cowen from $250.00 to $255.00. The firm currently has a buy rating on the stock.
Lantheus (NASDAQ:LNTH) had its target price increased by Mizuho from $72.00 to $85.00. The firm currently has an outperform rating on the stock.
Lowe’s Companies (NYSE:LOW) had its price target increased by Mizuho from $272.00 to $294.00. Mizuho currently has an outperform rating on the stock.
Lsb Industries (NYSE:LXU) had its price target increased by Royal Bank Of Canada from $11.00 to $13.00. The firm currently has an outperform rating on the stock.
Marathon Digital (NASDAQ:MARA) had its target price trimmed by Cantor Fitzgerald from $21.00 to $11.00. They currently have an overweight rating on the stock.
Medline (NASDAQ:MDLN) had its target price raised by Wells Fargo & Company from $42.00 to $47.00. They currently have an equal weight rating on the stock.
Ramaco Resources (NASDAQ:METC) had its price target cut by Robert W. Baird from $40.00 to $30.00. The firm currently has an outperform rating on the stock.
Magnite (NASDAQ:MGNI) had its price target reduced by Wells Fargo & Company from $20.00 to $13.00. The firm currently has an equal weight rating on the stock.
Middleby (NASDAQ:MIDD) had its target price boosted by KeyCorp from $175.00 to $190.00. KeyCorp currently has an overweight rating on the stock.
Middleby (NASDAQ:MIDD) had its target price increased by Robert W. Baird from $159.00 to $197.00. The firm currently has an outperform rating on the stock.
MannKind (NASDAQ:MNKD) had its target price trimmed by Wells Fargo & Company from $8.00 to $7.00. Wells Fargo & Company currently has an overweight rating on the stock.
Monster Beverage (NASDAQ:MNST) had its price target increased by Stifel Nicolaus from $82.00 to $92.00. Stifel Nicolaus currently has a buy rating on the stock.
Monster Beverage (NASDAQ:MNST) had its target price boosted by Citigroup Inc. from $90.00 to $100.00. The firm currently has a buy rating on the stock.
Monster Beverage (NASDAQ:MNST) had its target price raised by Wells Fargo & Company from $86.00 to $94.00. Wells Fargo & Company currently has an overweight rating on the stock.
Monster Beverage (NASDAQ:MNST) had its target price increased by JPMorgan Chase & Co. from $79.00 to $81.00. The firm currently has a neutral rating on the stock.
Monster Beverage (NASDAQ:MNST) had its price target boosted by UBS Group AG from $84.00 to $92.00. The firm currently has a neutral rating on the stock.
Monster Beverage (NASDAQ:MNST) had its target price raised by Piper Sandler from $85.00 to $94.00. They currently have an overweight rating on the stock.
Monster Beverage (NASDAQ:MNST) had its price target increased by Jefferies Financial Group Inc. from $80.00 to $100.00. The firm currently has a buy rating on the stock.
Monster Beverage (NASDAQ:MNST) had its price target boosted by TD Cowen from $80.00 to $88.00. TD Cowen currently has a hold rating on the stock.
Monster Beverage (NASDAQ:MNST) had its target price increased by Deutsche Bank Aktiengesellschaft from $88.00 to $94.00. The firm currently has a buy rating on the stock.
Nautilus Biotechnology (NASDAQ:NAUT) had its target price increased by Guggenheim from $2.50 to $4.00. The firm currently has a buy rating on the stock.
Nuveen Churchill Direct Lending (NYSE:NCDL) had its target price lowered by Keefe, Bruyette & Woods from $16.00 to $15.00. The firm currently has a market perform rating on the stock.
Netflix (NASDAQ:NFLX) had its price target raised by Rosenblatt Securities from $94.00 to $95.00. Rosenblatt Securities currently has a neutral rating on the stock.
Netflix (NASDAQ:NFLX) had its target price boosted by Wolfe Research from $95.00 to $110.00. The firm currently has an outperform rating on the stock.
Ingevity (NYSE:NGVT) had its target price boosted by Wells Fargo & Company from $65.00 to $75.00. The firm currently has an equal weight rating on the stock.
Natera (NASDAQ:NTRA) had its target price boosted by Robert W. Baird from $239.00 to $257.00. The firm currently has an outperform rating on the stock.
Natera (NASDAQ:NTRA) had its price target boosted by Wells Fargo & Company from $205.00 to $215.00. The firm currently has an equal weight rating on the stock.
Nuvalent (NASDAQ:NUVL) had its price target boosted by Cantor Fitzgerald from $135.00 to $140.00. They currently have an overweight rating on the stock.
Novavax (NASDAQ:NVAX) had its price target boosted by HC Wainwright from $11.00 to $16.00. They currently have a buy rating on the stock.
NVIDIA (NASDAQ:NVDA) had its price target increased by CICC Research from $228.00 to $240.60. The firm currently has an outperform rating on the stock.
Nexstar Media Group (NASDAQ:NXST) had its target price raised by Guggenheim from $250.00 to $290.00. The firm currently has a buy rating on the stock.
Nexstar Media Group (NASDAQ:NXST) had its price target increased by Wells Fargo & Company from $250.00 to $290.00. The firm currently has an overweight rating on the stock.
Nexstar Media Group (NASDAQ:NXST) had its price target increased by Benchmark Co. from $250.00 to $300.00. The firm currently has a buy rating on the stock.
Realty Income (NYSE:O) had its target price increased by Cantor Fitzgerald from $60.00 to $68.00. Cantor Fitzgerald currently has a neutral rating on the stock.
Okta (NASDAQ:OKTA) had its target price cut by Cantor Fitzgerald from $115.00 to $100.00. Cantor Fitzgerald currently has an overweight rating on the stock.
BeOne Medicines (NASDAQ:ONC) had its price target boosted by Truist Financial Corporation from $400.00 to $412.00. The firm currently has a buy rating on the stock.
BeOne Medicines (NASDAQ:ONC) had its price target increased by Barclays PLC from $394.00 to $405.00. They currently have an overweight rating on the stock.
BeOne Medicines (NASDAQ:ONC) had its price target increased by Guggenheim from $400.00 to $410.00. The firm currently has a buy rating on the stock.
Ormat Technologies (NYSE:ORA) had its target price reduced by TD Cowen from $131.00 to $125.00. They currently have a buy rating on the stock.
Ormat Technologies (NYSE:ORA) had its target price reduced by Robert W. Baird from $143.00 to $130.00. The firm currently has an outperform rating on the stock.
Organogenesis (NASDAQ:ORGO) had its price target cut by BTIG Research from $9.00 to $8.00. BTIG Research currently has a buy rating on the stock.
OUTFRONT Media (NYSE:OUT) had its target price increased by Wells Fargo & Company from $27.00 to $30.00. They currently have an overweight rating on the stock.
PACS Group (NYSE:PACS) had its target price boosted by Royal Bank Of Canada from $47.00 to $52.00. The firm currently has an outperform rating on the stock.
PAR Technology (NYSE:PAR) had its target price reduced by BTIG Research from $60.00 to $45.00. The firm currently has a buy rating on the stock.
PAR Technology (NYSE:PAR) had its target price reduced by Needham & Company LLC from $55.00 to $30.00. They currently have a buy rating on the stock.
PAR Technology (NYSE:PAR) had its target price reduced by Stephens from $60.00 to $45.00. Stephens currently has an overweight rating on the stock.
Par Pacific (NYSE:PARR) had its price target raised by TD Cowen from $39.00 to $48.00. TD Cowen currently has a buy rating on the stock.
Payoneer Global (NASDAQ:PAYO) had its target price reduced by Keefe, Bruyette & Woods from $7.50 to $7.00. The firm currently has an outperform rating on the stock.
PureCycle Technologies (NASDAQ:PCT) had its target price cut by Cantor Fitzgerald from $16.00 to $14.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Public Service Enterprise Group (NYSE:PEG) had its target price increased by Wells Fargo & Company from $92.00 to $94.00. They currently have an overweight rating on the stock.
PENN Entertainment (NASDAQ:PENN) had its target price boosted by Deutsche Bank Aktiengesellschaft from $16.00 to $17.00. The firm currently has a hold rating on the stock.
Phathom Pharmaceuticals (NASDAQ:PHAT) had its target price boosted by Guggenheim from $20.00 to $25.00. Guggenheim currently has a buy rating on the stock.
Personalis (NASDAQ:PSNL) had its target price boosted by Needham & Company LLC from $10.00 to $12.00. The firm currently has a buy rating on the stock.
Papa John’s International (NASDAQ:PZZA) had its target price cut by Stephens from $49.00 to $40.00. They currently have an overweight rating on the stock.
Papa John’s International (NASDAQ:PZZA) had its price target trimmed by Benchmark Co. from $60.00 to $50.00. The firm currently has a buy rating on the stock.
Qnity Electronics (NYSE:Q) had its price target boosted by KeyCorp from $117.00 to $147.00. The firm currently has an overweight rating on the stock.
D-Wave Quantum (NYSE:QBTS) had its target price lowered by Roth Mkm from $40.00 to $30.00. Roth Mkm currently has a buy rating on the stock.
D-Wave Quantum (NYSE:QBTS) had its price target lowered by Mizuho from $46.00 to $40.00. The firm currently has an outperform rating on the stock.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its price target raised by Wells Fargo & Company from $70.00 to $75.00. The firm currently has an equal weight rating on the stock.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its price target boosted by Guggenheim from $79.00 to $80.00. The firm currently has a buy rating on the stock.
Rocket Pharmaceuticals (NASDAQ:RCKT) had its target price boosted by Cantor Fitzgerald from $8.00 to $10.00. The firm currently has an overweight rating on the stock.
RealReal (NASDAQ:REAL) had its target price boosted by Robert W. Baird from $15.00 to $16.00. The firm currently has a neutral rating on the stock.
Rocket Lab (NASDAQ:RKLB) had its price target raised by Cantor Fitzgerald from $72.00 to $85.00. The firm currently has an overweight rating on the stock.
Rocket Companies (NYSE:RKT) had its target price raised by Wells Fargo & Company from $17.00 to $19.00. The firm currently has an equal weight rating on the stock.
Relay Therapeutics (NASDAQ:RLAY) had its price target raised by Wells Fargo & Company from $13.00 to $15.00. They currently have an overweight rating on the stock.
Sunrun (NASDAQ:RUN) had its target price raised by Oppenheimer Holdings, Inc. from $23.00 to $25.00. The firm currently has an outperform rating on the stock.
Rackspace Technology (NASDAQ:RXT) had its price target increased by Royal Bank Of Canada from $1.75 to $2.50. Royal Bank Of Canada currently has a sector perform rating on the stock.
Ryan Specialty (NYSE:RYAN) had its target price reduced by Mizuho from $53.00 to $44.00. They currently have a neutral rating on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its price target increased by Citizens Jmp from $167.00 to $176.00. They currently have a market outperform rating on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its price target boosted by Guggenheim from $140.00 to $143.00. They currently have a buy rating on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its price target trimmed by Wells Fargo & Company from $145.00 to $136.00. Wells Fargo & Company currently has an overweight rating on the stock.
SBA Communications (NASDAQ:SBAC) had its price target reduced by Wells Fargo & Company from $205.00 to $195.00. The firm currently has an equal weight rating on the stock.
ServisFirst Bancshares (NYSE:SFBS) had its target price boosted by Hovde Group from $92.00 to $97.00. The firm currently has an outperform rating on the stock.
Sweetgreen (NYSE:SG) had its price target reduced by Royal Bank Of Canada from $8.00 to $7.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Sweetgreen (NYSE:SG) had its price target reduced by Oppenheimer Holdings, Inc. from $10.00 to $9.00. They currently have an outperform rating on the stock.
Shake Shack (NYSE:SHAK) had its price target raised by Robert W. Baird from $104.00 to $108.00. The firm currently has a neutral rating on the stock.
Shake Shack (NYSE:SHAK) had its target price boosted by Wells Fargo & Company from $90.00 to $100.00. Wells Fargo & Company currently has an equal weight rating on the stock.
J. M. Smucker (NYSE:SJM) had its target price increased by Sanford C. Bernstein from $113.00 to $121.00. They currently have a market perform rating on the stock.
J. M. Smucker (NYSE:SJM) had its target price boosted by Wells Fargo & Company from $120.00 to $135.00. They currently have an overweight rating on the stock.
Skyward Specialty Insurance Group (NASDAQ:SKWD) had its target price increased by Keefe, Bruyette & Woods from $69.00 to $70.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Soleno Therapeutics (NASDAQ:SLNO) had its target price lowered by Wells Fargo & Company from $114.00 to $110.00. The firm currently has an overweight rating on the stock.
Solventum (NYSE:SOLV) had its target price lowered by Wells Fargo & Company from $86.00 to $83.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Solventum (NYSE:SOLV) had its price target boosted by KeyCorp from $97.00 to $99.00. KeyCorp currently has an overweight rating on the stock.
Sprout Social (NASDAQ:SPT) had its target price lowered by Needham & Company LLC from $32.00 to $14.00. Needham & Company LLC currently has a buy rating on the stock.
Sprout Social (NASDAQ:SPT) had its target price reduced by KeyCorp from $9.00 to $6.00. They currently have an underweight rating on the stock.
Sempra Energy (NYSE:SRE) had its price target boosted by Wells Fargo & Company from $112.00 to $113.00. Wells Fargo & Company currently has an overweight rating on the stock.
Sarepta Therapeutics (NASDAQ:SRPT) had its price target lowered by Wells Fargo & Company from $45.00 to $38.00. Wells Fargo & Company currently has an overweight rating on the stock.
E.W. Scripps (NASDAQ:SSP) had its target price increased by Benchmark Co. from $8.00 to $10.00. Benchmark Co. currently has a buy rating on the stock.
Sensata Technologies (NYSE:ST) had its price target raised by Oppenheimer Holdings, Inc. from $43.00 to $50.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
USA Today (NYSE:TDAY) had its price target raised by Citizens Jmp from $6.00 to $8.00. They currently have a market outperform rating on the stock.
Teleflex (NYSE:TFX) had its price target boosted by Wells Fargo & Company from $116.00 to $130.00. They currently have an equal weight rating on the stock.
Teleflex (NYSE:TFX) had its price target raised by Royal Bank Of Canada from $115.00 to $125.00. The firm currently has a sector perform rating on the stock.
Target (NYSE:TGT) had its price target raised by Wells Fargo & Company from $115.00 to $130.00. Wells Fargo & Company currently has an overweight rating on the stock.
Targa Resources (NYSE:TRGP) had its target price raised by Royal Bank Of Canada from $218.00 to $260.00. They currently have an outperform rating on the stock.
Universal Health Services (NYSE:UHS) had its price target trimmed by Cantor Fitzgerald from $250.00 to $229.00. They currently have a neutral rating on the stock.
Energy Fuels (NYSEAMERICAN:UUUU) had its price target raised by HC Wainwright from $26.75 to $27.25. HC Wainwright currently has a buy rating on the stock.
UWM (NYSE:UWMC) had its price target trimmed by Keefe, Bruyette & Woods from $6.75 to $6.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Marriott Vacations Worldwide (NYSE:VAC) had its target price increased by Wells Fargo & Company from $46.00 to $58.00. They currently have an underweight rating on the stock.
Vericel (NASDAQ:VCEL) had its target price boosted by HC Wainwright from $60.00 to $64.00. The firm currently has a buy rating on the stock.
Vital Farms (NASDAQ:VITL) had its target price cut by Telsey Advisory Group from $50.00 to $35.00. They currently have an outperform rating on the stock.
Viridian Therapeutics (NASDAQ:VRDN) had its price target lowered by Royal Bank Of Canada from $45.00 to $42.00. The firm currently has an outperform rating on the stock.
VSE (NASDAQ:VSEC) had its target price increased by Royal Bank Of Canada from $225.00 to $250.00. They currently have an outperform rating on the stock.
Vistra (NYSE:VST) had its target price lowered by Wells Fargo & Company from $236.00 to $234.00. They currently have an overweight rating on the stock.
Warner Bros. Discovery (NASDAQ:WBD) had its target price increased by TD Cowen from $22.00 to $26.00. They currently have a hold rating on the stock.
Walker & Dunlop (NYSE:WD) had its target price trimmed by Keefe, Bruyette & Woods from $80.00 to $65.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Willis Towers Watson Public (NASDAQ:WTW) had its price target reduced by Mizuho from $392.00 to $358.00. The firm currently has an outperform rating on the stock.
TeraWulf (NASDAQ:WULF) had its target price increased by Cantor Fitzgerald from $18.00 to $24.00. They currently have an overweight rating on the stock.
Wolverine World Wide (NYSE:WWW) had its price target raised by KeyCorp from $24.00 to $25.00. KeyCorp currently has an overweight rating on the stock.
Wolverine World Wide (NYSE:WWW) had its price target boosted by Robert W. Baird from $23.00 to $27.00. Robert W. Baird currently has an outperform rating on the stock.
Wolverine World Wide (NYSE:WWW) had its target price boosted by Telsey Advisory Group from $18.00 to $22.00. They currently have a market perform rating on the stock.
Xenon Pharmaceuticals (NASDAQ:XENE) had its target price increased by Wells Fargo & Company from $48.00 to $49.00. The firm currently has an overweight rating on the stock.
Xponential Fitness (NYSE:XPOF) had its target price lowered by Robert W. Baird from $8.00 to $6.50. The firm currently has a neutral rating on the stock.
DENTSPLY SIRONA (NASDAQ:XRAY) had its price target raised by Robert W. Baird from $12.00 to $14.00. Robert W. Baird currently has a neutral rating on the stock.
DENTSPLY SIRONA (NASDAQ:XRAY) had its target price raised by Wells Fargo & Company from $12.00 to $13.00. The firm currently has an equal weight rating on the stock.
Block (NYSE:XYZ) had its price target increased by Needham & Company LLC from $80.00 to $90.00. They currently have a buy rating on the stock.
Block (NYSE:XYZ) had its target price increased by Oppenheimer Holdings, Inc. from $85.00 to $89.00. They currently have an outperform rating on the stock.
Zai Lab (NASDAQ:ZLAB) had its price target trimmed by Cantor Fitzgerald from $55.00 to $37.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Zscaler (NASDAQ:ZS) had its target price cut by Morgan Stanley from $305.00 to $200.00. Morgan Stanley currently has an overweight rating on the stock.
Zscaler (NASDAQ:ZS) had its price target reduced by Berenberg Bank from $390.00 to $320.00. They currently have a buy rating on the stock.
Zscaler (NASDAQ:ZS) had its price target cut by BMO Capital Markets from $315.00 to $210.00. BMO Capital Markets currently has an outperform rating on the stock.
Zscaler (NASDAQ:ZS) had its target price lowered by Citizens Jmp from $355.00 to $290.00. Citizens Jmp currently has a market outperform rating on the stock.
Zscaler (NASDAQ:ZS) had its target price trimmed by Oppenheimer Holdings, Inc. from $345.00 to $280.00. The firm currently has an outperform rating on the stock.
Zscaler (NASDAQ:ZS) had its price target trimmed by Mizuho from $265.00 to $250.00. They currently have an outperform rating on the stock.
Zscaler (NASDAQ:ZS) had its price target cut by Royal Bank Of Canada from $250.00 to $205.00. The firm currently has an outperform rating on the stock.
Zscaler (NASDAQ:ZS) had its target price cut by Needham & Company LLC from $310.00 to $180.00. Needham & Company LLC currently has a buy rating on the stock.
Zscaler (NASDAQ:ZS) had its price target reduced by Piper Sandler from $260.00 to $185.00. Piper Sandler currently has a neutral rating on the stock.
Receive News & Ratings for Applied Optoelectronics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Optoelectronics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
